Substituted aryl sulfonamides for use as sodium channel inhibitors

MDE20260718A1Pending Publication Date: 2026-10-31XENON PHARMACEUTICALS INC
0 Cites 0 Cited by

Patent Information

Application Number
MDE20260718T
Authority / Receiving Office
MD · MD
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-10-30
Publication Date
2026-10-31
Patent Text Reader

Abstract

The present disclosure provides compounds having Formula I: and the pharmaceutically acceptable salts, solvates, and stereoisomers thereof, wherein M1, M2, M3, M4, Z, n, R5, R6, W, A, and R9 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to inhibit sodium channels (e.g., Nav1.7) and / or to treat a disorder responsive to the inhibition of a sodium channel (e.g., Nav1.7). Compounds of the present disclosure may be useful for treating pain.
Need to check novelty before this filing date? Find Prior Art